These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Phosphatase PP2A enhances MCL-1 protein half-life in multiple myeloma cells. Slomp A; Moesbergen LM; Eldering E; Kersten MJ; Minnema MC; Peperzak V Cell Death Dis; 2021 Mar; 12(3):229. PubMed ID: 33658484 [TBL] [Abstract][Full Text] [Related]
45. Crosstalk and ultrasensitivity in protein degradation pathways. Mallela A; Nariya MK; Deeds EJ PLoS Comput Biol; 2020 Dec; 16(12):e1008492. PubMed ID: 33370258 [TBL] [Abstract][Full Text] [Related]
46. Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway. Gillies TE; Pargett M; Silva JM; Teragawa CK; McCormick F; Albeck JG Mol Syst Biol; 2020 Oct; 16(10):e9518. PubMed ID: 33073539 [TBL] [Abstract][Full Text] [Related]
47. Phosphatase POPX2 interferes with cell cycle by interacting with Chk1. Kim PR; Koon YL; Lee RTC; Azizan F; Koh DHZ; Chiam KH; Koh CG Cell Cycle; 2020 Feb; 19(4):405-418. PubMed ID: 31944151 [TBL] [Abstract][Full Text] [Related]
48. The Evolution of Tau Phosphorylation and Interactions. Trushina NI; Bakota L; Mulkidjanian AY; Brandt R Front Aging Neurosci; 2019; 11():256. PubMed ID: 31619983 [TBL] [Abstract][Full Text] [Related]
49. Assays for tyrosine phosphorylation in human cells. Kruk M; Widstrom N; Jena S; Wolter NL; Blankenhorn JF; Abdalla I; Yang TY; Parker LL Methods Enzymol; 2019; 626():375-406. PubMed ID: 31606083 [TBL] [Abstract][Full Text] [Related]
50. Robustness of Nutrient Signaling Is Maintained by Interconnectivity Between Signal Transduction Pathways. Welkenhuysen N; Schnitzer B; Österberg L; Cvijovic M Front Physiol; 2018; 9():1964. PubMed ID: 30719010 [TBL] [Abstract][Full Text] [Related]
51. Intrinsic limits of information transmission in biochemical signalling motifs. Suderman R; Deeds EJ Interface Focus; 2018 Dec; 8(6):20180039. PubMed ID: 30443336 [TBL] [Abstract][Full Text] [Related]
52. A Mathematical Model of the Phosphoinositide Pathway. Olivença DV; Uliyakina I; Fonseca LL; Amaral MD; Voit EO; Pinto FR Sci Rep; 2018 Mar; 8(1):3904. PubMed ID: 29500467 [TBL] [Abstract][Full Text] [Related]
53. Identification of PTPN1 as a novel negative regulator of the JNK MAPK pathway using a synthetic screening for pathway-specific phosphatases. Moon J; Ha J; Park SH Sci Rep; 2017 Oct; 7(1):12974. PubMed ID: 29021559 [TBL] [Abstract][Full Text] [Related]
54. Crosstalk and the Dynamical Modularity of Feed-Forward Loops in Transcriptional Regulatory Networks. Rowland MA; Abdelzaher A; Ghosh P; Mayo ML Biophys J; 2017 Apr; 112(8):1539-1550. PubMed ID: 28445746 [TBL] [Abstract][Full Text] [Related]
55. Phosphatase specificity and pathway insulation in signaling networks. Rowland MA; Harrison B; Deeds EJ Biophys J; 2015 Feb; 108(4):986-996. PubMed ID: 25692603 [TBL] [Abstract][Full Text] [Related]
56. Crosstalk and competition in signaling networks. Rowland MA; Fontana W; Deeds EJ Biophys J; 2012 Dec; 103(11):2389-98. PubMed ID: 23283238 [TBL] [Abstract][Full Text] [Related]
57. From promiscuity to precision: protein phosphatases get a makeover. Virshup DM; Shenolikar S Mol Cell; 2009 Mar; 33(5):537-45. PubMed ID: 19285938 [TBL] [Abstract][Full Text] [Related]
58. Serine/threonine phosphatases: mechanism through structure. Shi Y Cell; 2009 Oct; 139(3):468-84. PubMed ID: 19879837 [TBL] [Abstract][Full Text] [Related]
59. Regulated interaction of protein phosphatase 1 and protein phosphatase 2A with phospholipase C-related but catalytically inactive protein. Sugiyama G; Takeuchi H; Nagano K; Gao J; Ohyama Y; Mori Y; Hirata M Biochemistry; 2012 Apr; 51(16):3394-403. PubMed ID: 22458807 [TBL] [Abstract][Full Text] [Related]